Brainomix AI Analysis Finds Treatment Signals in CHARM Stroke Trial
Post-hoc analysis of Phase 3 CHARM data suggests NCCT-based infarct volume assessment could help identify patients who may respond to investigational CIRARA.
imaging and datamanagement